Cargando…

Prognostic ability of a panel of immunohistochemistry markers – retailoring of an 'old solution'

An urgent requirement exists for new prognostic and predictive assays in breast cancer. Despite the development of high-throughput technologies such as DNA microarrays, it would now appear that immunohistochemistry (IHC) may play an increasingly important role in the clinical management of breast ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brennan, Donal J, Gallagher, William M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374964/ https://www.ncbi.nlm.nih.gov/pubmed/18331621 http://dx.doi.org/10.1186/bcr1854

Ejemplares similares

The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers
por: Ong, Chee Wee, et al.
Publicado: (2015)

The core four - A panel of immunohistochemistry markers to diagnose and subtype testicular germ cell tumors
por: Ranjitha, V. N., et al.
Publicado: (2022)

Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification
por: Karnezis, Anthony N, et al.
Publicado: (2017)

Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer
por: Rexhepaj, Elton, et al.
Publicado: (2008)

Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer
por: Yu, Yue, et al.
Publicado: (2019)

Standardization of PD-L1 immunohistochemistry
por: Martinez-Morilla, Sandra, et al.
Publicado: (2021)

Immunohistochemistry Panel for Differential Diagnosis of Basal Cell Carcinoma and Trichoblastoma
por: Vega Memije, Maria Elisa, et al.
Publicado: (2014)

A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer()()
por: Voorneveld, Philip W., et al.
Publicado: (2015)

Immunohistochemistry on a panel of Emery–Dreifuss muscular dystrophy samples reveals nuclear envelope proteins as inconsistent markers for pathology
por: Le Thanh, Phu, et al.
Publicado: (2017)

Old problem may have new solution
por: Zhaori, Getu
Publicado: (2018)

An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer
por: Bennedsen, Astrid Louise Bjørn, et al.
Publicado: (2022)

Association between Immunohistochemistry Markers and Tumor Features and Their Diagnostic and Prognostic Values in Intrahepatic Cholangiocarcinoma
por: He, Jiannan, et al.
Publicado: (2022)

Prognostic markers for colorectal cancer
por: Tyrrell, Helen E.J., et al.
Publicado: (2018)

Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer
por: O´Leary, Patrick C, et al.
Publicado: (2013)

Retracted: Association between Immunohistochemistry Markers and Tumor Features and Their Diagnostic and Prognostic Values in Intrahepatic Cholangiocarcinoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Multiplex immunohistochemistry/immunofluorescence is superior to tumor mutational burden and PD‐L1 immunohistochemistry for predicting response to anti‐PD‐1/PD‐L1 immunotherapy
por: Hu, Weixian
Publicado: (2019)

Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry
por: Kim, Bo Wook, et al.
Publicado: (2013)

Ampullary carcinoma prognostic markers
por: Perkins, Geraldine, et al.
Publicado: (2019)

An Image Analysis Solution For Quantification and Determination of Immunohistochemistry Staining Reproducibility
por: Chlipala, Elizabeth A., et al.
Publicado: (2020)

Pre-analytic variables and phospho-specific antibodies: the Achilles heel of immunohistochemistry
por: Siddiqui, Summar, et al.
Publicado: (2010)

At last, a predictive and prognostic marker for radiotherapy?
por: Coates, Philip, et al.
Publicado: (2010)

Awakening of SCHLAFEN 11 by immunohistochemistry: a new biomarker predicting response to chemotherapy
por: Buettner, Reinhard
Publicado: (2021)

Diagnostic and Prognostic Markers in Liver Cirrhosis
por: Augustin, Salvador, et al.
Publicado: (2011)

Prognostic marker and target in prostate cancer
por: Lavorgna, Giovanni, et al.
Publicado: (2015)

Diagnostic and Prognostic Markers in Bladder Cancer
por: Ku, Ja Hyeon, et al.
Publicado: (2016)

ERG Immunohistochemistry as an Endothelial Marker for Assessing Lymphovascular Invasion
por: Kim, Sehun, et al.
Publicado: (2013)

Rhesus Macaque CODEX Multiplexed Immunohistochemistry Panel for Studying Immune Responses During Ebola Infection
por: Jiang, Sizun, et al.
Publicado: (2021)

Improving the State of the Science of Immunohistochemistry: The Histochemical Society’s Standards of Practice
por: Baskin, Denis G., et al.
Publicado: (2014)

Are the Immunohistochemistry-Based Biomarkers Helpful for Predicting Prognosis in Patients with Surgically Resected Cholangiocarcinoma?
por: Kim, Dong Uk
Publicado: (2023)

Language and medicine: Breaking the barriers in gynaecological cancer
por: Brennan, Donal J.
Publicado: (2021)

Diagnostic and prognostic implications of parafibromin immunohistochemistry in parathyroid carcinomaT
por: Pyo, Jung-Soo, et al.
Publicado: (2019)

Assessment of beta-catenin expression by immunohistochemistry in colorectal neoplasms and its role as an additional prognostic marker in colorectal adenocarcinoma
por: Bhattacharya, Indroneel, et al.
Publicado: (2019)

Prognostic significance of natural killer cell-associated markers in gastric cancer: quantitative analysis using multiplex immunohistochemistry
por: Na, Hee Young, et al.
Publicado: (2021)

Immunohistochemistry
por: HAWES, DEBRA, et al.
Publicado: (2009)

Expression sites of immunohistochemistry markers in oral diseases – A scoping review
por: Prabakaran, Rebekah C., et al.
Publicado: (2022)

New Prognostic and Predictive Markers in Cancer Progression
por: Costantini, Susan, et al.
Publicado: (2020)

Prognostic and predictive markers in glioblastoma and ALK overexpression
por: Kim, Jang-Hee
Publicado: (2021)

Detection of Putative Stem-cell Markers in Invasive Ductal Carcinoma of the Breast by Immunohistochemistry: Does It Improve Prognostic/Predictive Assessments?
por: Oliveira, Rodrigo V., et al.
Publicado: (2018)

Digital immunohistochemistry: new horizons and practical solutions in breast cancer pathology
por: Laurinavicius, Arvydas, et al.
Publicado: (2013)

Evaluation of natural killer cell (CD57) as a prognostic marker in oral squamous cell carcinoma: An immunohistochemistry study
por: Agarwal, Rashmi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g1lvcsile8caqoou4juuh2e66o